The US proposal to expand tariffs on imported generic medicines has created apprehension throughout the international pharmaceutical industry, especially India which is among the leading manufacturers of cheap generic medicines globally. As per the latest proposals made by US president Donald Trump, imported generic medicines would remain tax free for the next two years, be ...